BRCA2 and cancer: Our findings expand on prior work where the frequency of non-BRCA1/BRCA2 PVs for women with MPCs (BC and another cancer diagnosis, including a second BC diagnosis) was 8.5% (47/551) among those followed in a high-risk BC program [2].